SYP and colorectal adenocarcinoma: Furthermore, based on our data, we are not able to make further conclusions about the molecular underpinnings and possible differences in treatment response of synaptophysin-expressing conventional colorectal adenocarcinomas without a morphologically recognizable neuroendocrine component.